Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Nicotine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Discovery
Sponsor : Dr. Reddy\'s Laboratories
Deal Size : $632.9 million
Deal Type : Acquisition
Dr. Reddy's Acquire Nicotinell and Related Portfolio
Details : Through the acquisition, Reddy will leverage the NRT portfolio, which includes Nicotinell (nicotine) in various formats such as lozenges, patches, and gum, across all applicable global market.
Brand Name : Nicotinell
Molecule Type : Small molecule
Upfront Cash : $579.8 million
June 26, 2024
Lead Product(s) : Nicotine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Discovery
Sponsor : Dr. Reddy\'s Laboratories
Deal Size : $632.9 million
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?
Reset All
